🇺🇸 valganciclovir [Valcyte] in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Pain — 1 report (10%)
  2. Acinetobacter Test Positive — 1 report (10%)
  3. Anaemia — 1 report (10%)
  4. Back Pain — 1 report (10%)
  5. Blood Creatine Increased — 1 report (10%)
  6. Blood Lactate Dehydrogenase Increased — 1 report (10%)
  7. Blood Lactic Acid Increased — 1 report (10%)
  8. Complication Associated With Device — 1 report (10%)
  9. Cytokine Release Syndrome — 1 report (10%)
  10. Cytomegalovirus Infection — 1 report (10%)

Source database →

Other Infectious Disease / Virology approved in United States

Frequently asked questions

Is valganciclovir [Valcyte] approved in United States?

valganciclovir [Valcyte] does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for valganciclovir [Valcyte] in United States?

Hoffmann-La Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.